GLESSNER COLEEN (EVP, Quality & Ethics, and CPL) received a stock award from EMERGENT BIOSOLUTIONS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/1/2026ACC: 0001919170-26-000012
Officer· EVP, Quality & Ethics, and CPL
Since Mar 2022
+100.11K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100.11K
Price / share
—
Trade value
—
% of position
96.2%
4/29/2026
104.11K→204.22K
Total
Net shares
+100.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/29/2026 | A · Award | +100.11K | — | — | 96.2% | 104.11K | 204.22K |
| Total | +100.11K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported